Primobolan 200

Methenolone Enanthate — Primobolan 200 by Dragon Pharma

Primobolan 200 is Dragon Pharma's high-concentration formulation of Methenolone Enanthate at 200mg/ml — the same active compound as Primobolan 100 at twice the concentration per ml. For full scientific background on Methenolone's properties — including why it doesn't aromatise, its unique oral bioavailability, its reduced HPG suppression profile and its history — see the Primobolan 100 page. This page focuses on the practical case for the 200mg/ml formulation.

Also searched as: Methenolone Enanthate 200mg, Primobolan 200, Primo 200 Dragon Pharma, high-concentration Primobolan.

Why 200mg/ml — The Dose Economics Argument

Primobolan's modest anabolic ratio (88) means effective performance doses start at 400mg/week and often extend to 600-1000mg/week in experienced users. The concentration difference between 100mg/ml and 200mg/ml becomes operationally significant at these doses:

At 600mg/week with Primobolan 100, each twice-weekly injection is 3ml — a volume that is uncomfortable and impractical for a single injection site. With Primobolan 200, the same 600mg/week requires only 1.5ml per injection — a manageable single-site volume. For users running Primobolan at 600mg/week or above, the 200mg/ml formulation is practically essential.

The High-Dose Primobolan Rationale

Why do experienced users run Primo at 600-1000mg/week when the anabolic ratio is only 88?

• Methenolone's anabolic ratio understates its practical effect at the receptor level in certain tissue — in-vitro assays on which ratios are based don't fully capture in-vivo tissue-specific activity
• At high doses, Primobolan's mild suppression advantage is lost to some degree — but the lack of aromatisation, minimal androgenic side effects and non-hepatotoxic profile remain intact regardless of dose
• The combination of high Primobolan dose + moderate testosterone provides a unique stack: high total anabolic load from Primobolan's volume combined with testosterone's stronger AR binding for strength and androgenic function
• The "more Primo, less testosterone" approach at higher total doses reduces estrogen burden (since Primobolan doesn't aromatise) while maintaining meaningful anabolic activity — particularly valuable in pre-competition lean mass phases

Effects and Benefits

• Identical compound profile to Primobolan 100 — same Methenolone Enanthate properties
• Twice the concentration — half the injection volume for equivalent weekly doses
• Practical for doses above 400mg/week where 100mg/ml formulation creates uncomfortable injection volumes
• Same no-aromatisation, mild suppression, lean mass quality profile

Dosage and Administration